THROMB X NV has a total of 29 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are REESE RES FOUND, BIOMARIN PHARMACEUTICALS and PORTAGE PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Japan | 2 | |
#8 | Canada | 1 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | United States | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Pakola Steve | 6 |
#2 | Schoonjans Luc | 6 |
#3 | De Smet Marc | 5 |
#4 | Laroche Yves | 3 |
#5 | Collen Desire | 3 |
#6 | Collen Desire Jose | 3 |
#7 | Nagai Nubuo | 3 |
#8 | Molinas Sanabria Carlos Roger | 2 |
#9 | Steve Pakola | 2 |
#10 | Koninckx Phillppe | 2 |
Publication | Filing date | Title |
---|---|---|
GB0302074D0 | Embryonic stem cell | |
WO03054170A1 | Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells | |
GB0228409D0 | Pharmacological vitreolysis | |
GB0225128D0 | Laparoscopy and adhesion formation | |
GB0220145D0 | Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability | |
GB0219835D0 | Treatment of anemia | |
GB0202379D0 | Agent for the prevention or minimisation of post-operative adhesion formation and/or cell implantation | |
GB0201983D0 | Inhibitors of HIF | |
GB0201715D0 | Use of genetically modified multicellular animals in the identification of drug target proteins | |
WO03054169A1 | Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability |